Catalyst
Slingshot members are tracking this event:
Adaptimmune’s Investor Day (virtual) Nov 20, 2020
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ADAP |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 20, 2020
Occurred Source:
https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=&eventid=2825435&sessionid=1&key=BE93EC4ECE63E7F8D546FD78B163666B®Tag=&sourcepage=register
Related Projects
- Part 2: Discussing the ASCO 2020 presentation "Phase 1 Dose Escalation and Expansion Trial to Assess Safety and Efficacy of ADP-A2M4 in Advanced Solid Tumors" ADAP Executed On: Sep 10, 2020 at 04:00 PM EDT
Related Keywords
Tcr T-cell Immunotherapies, Next Generation Tcr, Off-the-shell Allogeneic Cell Therapy, Car-nk, Tcr Product, Haplo-independent Tcr (hit), Combination Therapy
